Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
doi: 10.1007/s00406-023-01734-3 123 ZhouTGuanRRosenthalSLMoerdlerSGuanZSunL
Target-mediated pharmacokinetic/pharmacodynamic model based meta-analysis and dosing regimen optimization of a long-acting release formulation of exenatide in patients with type 2 diabetes mellitus
Garg R, et al
Post-trial follow-up data from EMPA-KIDNEY suggest that cardiorenal benefits may persisted for up to 1 year after treatment cessation, highlighting the importance of continued therapy for long-term effectiveness [117]
A discussion of heat-related illnesses during heat waves, which are on the rise in our warming world, led a reader in Arizona to share a tip that comes from his grandmother
US$ 23.27
US$ 26.94
US$ 29.67
US$ 22.20
